Utah People's Post

The Latest News from the Beehive State

Wednesday, February 1, 2023
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / FDA’s no to wider use of Johnson & Johnson’s Xarelto drug

FDA’s no to wider use of Johnson & Johnson’s Xarelto drug

February 14, 2014 Posted by Contributor

In a major setback to drug maker Johnson & Johnson, the US Food and Drug Administration has rejected its drug application for a third time.

The firm has sought permission from the agency to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease. But much to the disappointment for the company, the FDA rejected its application citing lapses in the information about the pill’s benefits in the company’s studies.

The FDA panel of experts, who were examining the drug, unanimously voted against the broader use of the pill last month. According to the federal advisers, there were serious loops in the information in the company studies that could show Xarelto’s benefit accurately.

i9yC53xtZWXs

Sources said that J&J has made considerable efforts to fill in the missing data,  but the FDA panel found them unfit and not enough to reach firm conclusions about the relative safety and efficacy of rivaroxaban for use.

The drug was meant for the people affected with the condition when narrowed blood vessels restrict blood flow to the heart, increasing the risk of heart attack and other potentially deadly problems.

The FDA also turned down the company’s second proposal that the drug will reduce blood clots in patients who have received a stent, a mesh-metal tube used to open arteries that have been cleared of fatty plaque.

In an official statement released by the J&J soon after the rejection, the company said, “We are evaluating the contents of the letters and will determine the appropriate next steps.”

The FDA’s decision has also impacted the stocks market with Johnson & Johnson shares rose 23 cents to $92.79 in midday trading.

J&J reported Xarelto sales of $246 million in its last fiscal quarter.

 

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health Tagged With: drug, FDA, Food and Drug Administration, Johnson & Johnson, U.S., Xarelto

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

    Jun 29, 2018
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

    Jun 29, 2018
  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

    Jun 27, 2018
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

    Jun 25, 2018
  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

    Jun 22, 2018
  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

    Jun 21, 2018
  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

    Jun 19, 2018
  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

    Jun 18, 2018
  • Our Brains Are Craving Combinations of Fats and Carbs (Study)

    Jun 15, 2018
  • Hungry bird with beck open

    Scientists Explain Why We Get ‘Hangry’

    Jun 13, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2023 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact